Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Propofol Dose Reduction in Laparoscopic Surgery
NCT01158859Phase 4Completed
- Sponsor
- Université de Sherbrooke
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of pregabalin in anxiety disorder, sponsored by Université de Sherbrooke. Primary endpoint: Propofol induction dose at 1 hour. Started Apr 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01158859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158859.